Navigation Links
BSP's New Line of HyperQ Products: Bedside Ischemia Monitoring Systems Announces Successful Results of First Feasibility Study
Date:2/26/2008

BSP's HyperQ(TM) Monitoring System will Allow Bedside Detection of Ischemic

Events and Myocardial Infarction (Heart Attack)

TEL AVIV, Israel, February 26 /PRNewswire/ -- BSP (Biological Signal Processing Ltd.) an Israeli company which develops and markets systems for non-invasive diagnosis and monitoring of ischemic heart disease, announces successful results in detecting ischemic events using its proprietary HyperQ technology in resting conditions.

The successful results of the study indicate that the HyperQ(TM) technology, based on sophisticated analysis of high-frequency ECG components, can be implemented in two products: (i) bedside monitoring system for early detection of transient ischemic episodes and (ii) a resting ECG system for sensitive diagnosis of acute coronary syndrome, including myocardial infarction. A highly important clinical application of these two devices is the identification of heart attacks that are not accompanied by changes in standard ECG.

The results of the study showed that both HyperQ(TM) indices detected ischemia more accurately than ST analysis. Overall accuracy of HyperQ-based analysis was found to be 96% for the intensity-based index and 82% for the morphology-based index, both significantly higher than the accuracy of the conventional ST segment analysis at 75%.

"We are proud to present the first results that indicate clearly the HyperQ's strength in ischemia monitoring in a resting condition," said Dr. Amir Beker, Founder & CEO of BSP. "This carries an immense clinical value to cardiac patients, and marks the feasibility of BSP's next product line - the monitoring and resting HyperQ systems, which are planned to be offered to the market by early 2009. BSP will launch the commercial introduction of the HyperQ(TM) Stress System in the US at the 57th ACC Meeting this March." added Dr. Beker.

About BSP

BSP is dedicated to providing novel, risk free and highly reliable solutions for the diagnosis and monitoring of Ischemic Heart Disease. BSP's HyperQ technology is implemented in cardiac systems that offer highly reliable, low-cost and risk free cardiac monitoring and allows, for the first time, an effective diagnosis of Ischemic Heart Diseases in broad populations. BSP's HyperQ(TM) System for Stress Tests has received FDA clearance and obtained CE marking.

BSP was founded in 2000 by Dr. Amir Beker, and Ariel Landau, had completed a successful IPO in mid-2006 and is traded on the Tel Aviv Stock Exchange.

Contact:

Dr. Amir Beker,

+972-3-6474840

http://www.bspmedical.com


'/>"/>
SOURCE BSP - Biological Signal Processing Ltd
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Microtest Offers Free White Paper: Virus Testing for Biological Products: Partnering With a Contract Lab
2. CleveMed Receives $1.5 Million in NIH Funding to Further Develop a Portable System for Monitoring Parkinsons Disease Motor Symptoms
3. DermTech Is Issued U.S. Patent for the Early Detection, Staging and Monitoring of Melanoma
4. BioMS Medicals pivotal international multiple sclerosis trial receives positive review from Data Safety Monitoring Board
5. Independent Data Safety Monitoring Board Recommends Continuation of Sangarts Pivotal Phase III Trials of Hemospan(R)
6. BioMS Medicals phase III U.S. multiple sclerosis trial receives positive safety review from Data Safety Monitoring Board
7. BioMS Medicals relapsing-remitting multiple sclerosis trial receives positive review from Data Safety Monitoring Board
8. Oridion Launches its Fully Integrated Remote Monitoring System and SARA Software for Improved Patient Safety
9. Masimo Launches Patient SafetyNet and Showcases the Rainbow SET Upgradable Noninvasive Monitoring Platform at 2007 ASA Annual Meeting
10. Boston Scientific Releases Remote Monitoring Data from its Wireless LATITUDE(R) Patient Management System
11. Arena Pharmaceuticals Continues Phase 3 BLOOM Obesity Trial Following Independent Echocardiographic Data Safety Monitoring Board Review
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... (PRWEB) , ... January 19, ... ... of advanced software solutions for pharmaceutical research and development (R&D), today announced ... in omic data analysis and interpretation for the rapidly evolving field of ...
(Date:1/19/2017)... (PRWEB) , ... January 18, 2017 , ... ... National Institutes of Health (NIH) to update its Data Sharing Policy. Specifically, the ... element of grant applications subject to the existing policy. AMIA recommended that NIH ...
(Date:1/19/2017)... 18, 2017  Northwest Biotherapeutics, Inc. (OTCQB: NWBO) ("NW ... therapies for operable and inoperable solid tumor cancers, announced ... Officer of NW Bio, will present at the Phacilitate ... the Hyatt Regency Hotel in Miami, Florida ... session entitled "New Therapeutic Approaches – Expanding the Reach ...
(Date:1/18/2017)...   Boston Biomedical , an industry leader in ... stemness pathways, will feature data from two clinical studies ... ASCO Gastrointestinal Cancers Symposium, held from January 19-21, in ... Napabucasin is an orally-administered investigational agent designed to inhibit ... stem cells (CSCs) possess the property of stemness – ...
Breaking Biology Technology:
(Date:1/13/2017)... Jan. 13, 2017 Sandata Technologies, LLC, ... the homecare industry, including Electronic Visit Verification™ (EVV™), ... Justin Jugs, as Senior Vice President of Product ... years of homecare experience to Sandata, where he ... plans to align Sandata,s suite of solutions with ...
(Date:1/11/2017)... Jan. 11, 2017 Intoxalock, a leading ignition ... release of its patent-pending calibration device. With this new ... calibrations, securely upload data logs and process repairs at ... "Fighting drunk driving through the application of ... at large, but also for the customer who can ...
(Date:1/6/2017)... -- Delta ID Inc., a leader in consumer-grade iris scanning ... CES® 2017. Delta ID has collaborated with Gentex Corporation ... of iris scanning as a secure, reliable and convenient ... car, and as a way to elevate the security ... ID and Gentex will demonstrate (booth #7326 LVCC) a ...
Breaking Biology News(10 mins):